About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Seattle | 403 Studies

Clinical Trials Prostate CancerSeattle

Prostate Cancer Clinical Trials in Seattle

Find 403 clinical trials for prostate cancer near Seattle, Washington. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Seattle

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 101-120 of 403 trials

TerminatedGVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate CancerThe purpose of this study is to compare the duration of survival between GVAX® immunotherapy for prostate cancer and chemotherapy treatment in patients with prostate cancer who no…NCT00089856·Alabaster, Alabama and 125 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingA Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)The purpose of this substudy is to assess the efficacy and safety of ifinatamab deruxtecan (I-DXd), given alone or with other treatments in participants with metastatic…NCT06863272·Los Angeles, California and 81 others

CompletedPROvenge Treatment and Early Cancer TreatmentThe PROTECT-PROvenge Treatment and Early Cancer Treatment trial was a Phase III trial for patients with hormone sensitive prostate cancer.NCT00779402·Berkeley, California and 17 others

CompletedEnzalutamide/Leuprolide +/- Abiraterone/Pred in ProstateThis study is comparing the effectiveness of enzalutamide with or without abiraterone acetate for men with high-risk, localized prostate cancer.NCT02268175·Baltimore, Maryland and 3 others

CompletedEffects of ASA on Prostate TissueAspirin affects many physiological processes through its anti-inflammatory actions.NCT00234299·Seattle, Washington

CompletedStudy of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate CancerMulticenter study in which patients with metastatic hormone refractory prostate cancer (HRPC), who have not had previous chemotherapy or immunotherapy treatments, received MDX-010…NCT00323882·Los Angeles, California and 13 others

CompletedTechnology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET StudyThis trial performs user testing of a mobile-friendly patient history collection and genetic education tool to improve healthcare providers' understanding of prostate cancer…NCT04447703·New York, New York and 4 others

RecruitingDocetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA ResponseThis study is being done to answer the following question: can the chance of prostate cancer growing or spreading be lowered by adding a drug to the usual combination of drugs?NCT06592924·Anchorage, Alaska and 394 others

RecruitingA Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)Researchers are looking for new ways to treat metastatic castration-resistant prostate cancer (mCRPC).NCT06925737·Phoenix, Arizona and 302 others

CompletedIntramuscular Mechanisms of Androgen Deprivation-related SarcopeniaProstate cancer (PCa) is the most common cancer among men and is even more common in the military and veteran population.NCT03867357·Seattle, Washington

Active not recruitingMedtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)This study will evaluate the safety and performance of the Medtronic Hugo™ RAS System when used for urologic RAS procedures.NCT05696444·Duarte, California and 5 others

CompletedObservational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate CancerObservational study in the routine clinical practice setting to evaluate the short and long term safety profile of Radium-223 in metastatic castration resistant prostate cancer…NCT02141438·Anchorage, Alaska and 67 others

Active not recruitingA Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer ImagingThe primary aim of this study is to determine whether a multi-modal, physician-focused behavioral intervention can improve facility-level guideline-concordant utilization of…NCT03445559·Palo Alto, California and 10 others

TerminatedPrime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate CancerThis is a multi-centre, Phase 1/2, open-label clinical trial of the VTP-850 prime-boost immunotherapeutic in men with biochemical recurrence after definitive local therapy for…NCT05617040·St Louis, Missouri and 6 others

CompletedA Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation TherapyParticipants who completed the FE200486 CS21 study (NCT00295750) could enter the FE200486 CS21A study.NCT00451958·Homewood, Alabama and 68 others

CompletedCarbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the BoneRATIONALE: Imaging procedures, such as PET scan, may help doctors predict a patient's response to treatment and help plan the best treatment.NCT00392938·Seattle, Washington and 1 other

CompletedABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the BodyA clinical trial examining the safety and effectiveness of ABX-EGF when given to patients with prostate cancer with or without tumor in other parts of the body.NCT00061126·Birmingham, Alabama and 8 others

CompletedStudy of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate CancerThe primary objective of this study was to compare the two alternate primary endpoints of radiographic progression-free survival (rPFS) and overall survival (OS) in patients with…NCT03511664·Scottsdale, Arizona and 87 others

RecruitingTreating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET ImagingThis phase III trial tests two questions by two separate comparisons of therapies.NCT04423211·Anchorage, Alaska and 340 others

UnknownBevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate CancerRATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread.NCT00348998·Seattle, Washington

PreviousPage 6 of 21Next

Other Conditions in Seattle

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma